Wod M, et al. - This study aimed to characterize metabolic risk profiles in diabetes stratified according to age at onset, fasting C-peptide and GAD autoantibodies (GADab). Findings demonstrated that groups of diabetics with clinically relevant differences in glycaemic control and cardiometabolic risk were defined according to fasting C-peptide and GADab status, but not age at onset.